GSK completes $2 billion acquisition of liver disease drug efimosfermin

Related
Byrna Technologies Q2 2025 Earnings Preview
5 minutes ago
0
The rules for paying taxes on tips and overtime are changing...
6 minutes ago
0
RxSight stock falls after Wells, BTIG downgrade on poor resu...
13 minutes ago
0
BlackRock debuts ETF to capture S&P 500 minus the mega-caps
16 minutes ago
0
GeneDx a new overweight at Piper Sandler on rare diseases te...
16 minutes ago
0
Intercontinental Exchange sees record H1 trading volume
17 minutes ago
0
Nvidia hits $4 trillion market cap
17 minutes ago
0
BofA upgrades Warner Music to 'neutral' on cost-cutting, JV ...
20 minutes ago
0
Wingstop gains after William Blair points to a long runway o...
27 minutes ago
0
Blackstone, TPG in talks to bid on H&R REIT assets - report
33 minutes ago
0
Why two-time founder and MacArthur Genius Daphne Koller sees...
33 minutes ago
0
Hims & Hers plans Canada expansion to time patent cliff for ...
34 minutes ago
0
Global X Enhanced Bitcoin Covered Call ETF declares $0.175 d...
38 minutes ago
0
Global X Bitcoin Covered Call ETF declares $0.14 dividend
38 minutes ago
0
TechnipFMC, Vaar Energi to partner for development of North ...
40 minutes ago
0
Gen Z are ‘overemployed,’ holding down 5 jobs and earning ov...
46 minutes ago
0
YieldMax BRK.B Option Income Strategy ETF declares $0.5029 d...
48 minutes ago
0
YieldMax Short TSLA Option Income Strategy ETF declares $0.2...
49 minutes ago
0
YieldMax ARKK Innovation Option Income Strategy ETF declares...
51 minutes ago
0
MongoDB rises after Wolfe Research starts coverage with bull...
53 minutes ago
0